Relief Therapeutics Holding AG (RLFTF)

[aGuyUS]

EAP-Expanded Access Protocol- RLF-100 has had since 7/29/2020
See Corporate press release Here

https://relieftherapeutics.com/fda-grants-expanded-access-protocol-to-rlf-100-aviptadil-for-respiratory-failure-in-covid-19/#_ftn1

EAP- Expanded Access Protocol- had to meet SPECIFIC CONDITIONS under which it was to be administered such as Hospitals Criteria, Doctors Criteria and the Patient had to be beyond or out of the range of the Clinical Trials acceptance criteria for Patients

EUA- EMERGENCY USE AUTHORIZATION is the same AUTHORIZATION that Gilead's "Redemsivir" has currently... RLF-100 if granted this EUA will be the 3rd Treatment to have been granted "AUTHORIZATION" by the FDA to treat COVID 19... the 1st being Redemsivir, 2nd Convalescent Plasma

IT makes this an entirely different Ball Game ...front and center as a leading treatment in COVID cases

Here Read allot of RLTFT pertinent Information at My DOCUMENT HERE

https://docs.google.com/document/d/1CboxDEE1uR4C0DsgXlsQ_01IfO3o45Oq0Chi712QuP0/edit#